NKGen Biotech (NKGNW) Competitors

$0.0002 0.00 (0.00%)
As of 11/6/2026

NKGNW vs. ALVOW, APLMW, BIAFW, BIVIW, and CDIOW

Should you buy NKGen Biotech stock or one of its competitors? NKGen Biotech's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), bioAffinity Technologies (BIAFW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does NKGen Biotech compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and NKGen Biotech (NASDAQ:NKGNW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership.

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
NKGen Biotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$489.61MN/AN/AN/AN/A
NKGen BiotechN/AN/AN/AN/AN/A

In the previous week, Alvotech had 2 more articles in the media than NKGen Biotech. MarketBeat recorded 3 mentions for Alvotech and 1 mentions for NKGen Biotech. NKGen Biotech's average media sentiment score of 0.00 beat Alvotech's score of -0.02 indicating that NKGen Biotech is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alvotech
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
NKGen Biotech
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Alvotech beats NKGen Biotech on 2 of the 3 factors compared between the two stocks.

How does NKGen Biotech compare to Apollomics?

NKGen Biotech (NASDAQ:NKGNW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.

In the previous week, NKGen Biotech had 1 more articles in the media than Apollomics. MarketBeat recorded 1 mentions for NKGen Biotech and 0 mentions for Apollomics. Apollomics' average media sentiment score of 1.79 beat NKGen Biotech's score of 0.00 indicating that Apollomics is being referred to more favorably in the news media.

Company Overall Sentiment
NKGen Biotech Neutral
Apollomics Very Positive

Company Net Margins Return on Equity Return on Assets
NKGen BiotechN/A N/A N/A
Apollomics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NKGen BiotechN/AN/AN/AN/AN/A
ApollomicsN/AN/AN/AN/AN/A

Summary

NKGen Biotech and Apollomics tied by winning 1 of the 2 factors compared between the two stocks.

How does NKGen Biotech compare to bioAffinity Technologies?

NKGen Biotech (NASDAQ:NKGNW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

In the previous week, NKGen Biotech had 1 more articles in the media than bioAffinity Technologies. MarketBeat recorded 1 mentions for NKGen Biotech and 0 mentions for bioAffinity Technologies. bioAffinity Technologies' average media sentiment score of 1.25 beat NKGen Biotech's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
NKGen Biotech Neutral
bioAffinity Technologies Positive

Company Net Margins Return on Equity Return on Assets
NKGen BiotechN/A N/A N/A
bioAffinity Technologies N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NKGen BiotechN/AN/AN/AN/AN/A
bioAffinity Technologies$5.47MN/AN/AN/AN/A

Summary

bioAffinity Technologies beats NKGen Biotech on 2 of the 3 factors compared between the two stocks.

How does NKGen Biotech compare to BioVie?

BioVie (NASDAQ:BIVIW) and NKGen Biotech (NASDAQ:NKGNW) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

In the previous week, NKGen Biotech had 1 more articles in the media than BioVie. MarketBeat recorded 1 mentions for NKGen Biotech and 0 mentions for BioVie. BioVie's average media sentiment score of 0.39 beat NKGen Biotech's score of 0.00 indicating that BioVie is being referred to more favorably in the media.

Company Overall Sentiment
BioVie Neutral
NKGen Biotech Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
NKGen BiotechN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
NKGen Biotech N/A N/A N/A

Summary

BioVie and NKGen Biotech tied by winning 1 of the 2 factors compared between the two stocks.

How does NKGen Biotech compare to Cardio Diagnostics?

NKGen Biotech (NASDAQ:NKGNW) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.

In the previous week, NKGen Biotech had 1 more articles in the media than Cardio Diagnostics. MarketBeat recorded 1 mentions for NKGen Biotech and 0 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 1.79 beat NKGen Biotech's score of 0.00 indicating that Cardio Diagnostics is being referred to more favorably in the news media.

Company Overall Sentiment
NKGen Biotech Neutral
Cardio Diagnostics Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NKGen BiotechN/AN/AN/AN/AN/A
Cardio Diagnostics$15.19KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
NKGen BiotechN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

Summary

Cardio Diagnostics beats NKGen Biotech on 2 of the 3 factors compared between the two stocks.

Get NKGen Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for NKGNW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NKGNW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NKGNW vs. The Competition

MetricNKGen BiotechBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$4.06B$7.82B$11.74B
Dividend YieldN/A3.63%2.47%4.47%
P/E RatioN/A25.6832.7626.82
Price / SalesN/A16.068.565.70
Price / CashN/A22.9521.0121.90
Price / BookN/A4.184.463.72
Net IncomeN/A-$24.15M$3.52B$393.10M
7 Day PerformanceN/A-7.25%-5.47%-4.73%
1 Month PerformanceN/A-5.98%-4.57%-7.14%
1 Year PerformanceN/A-7.72%-1.79%-7.51%

NKGen Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NKGNW
NKGen Biotech
N/A$0.00
flat
N/AN/A$0.00N/AN/A63
ALVOW
Alvotech
N/A$0.20
flat
N/A-77.5%$0.00$491.95MN/A1,460
APLMW
Apollomics
N/A$0.01
+2.9%
N/A-37.1%$0.00N/AN/A15
BIAFW
bioAffinity Technologies
N/A$0.21
+40.8%
N/A-37.6%$0.00$5.85MN/A57
BIVIW
BioVie
N/A$0.25
-12.9%
N/AN/A$0.00N/AN/A13

Related Companies and Tools


This page (NASDAQ:NKGNW) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners